Julia Hegge

1.7k total citations
44 papers, 1.3k citations indexed

About

Julia Hegge is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Julia Hegge has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Julia Hegge's work include Cardiac Ischemia and Reperfusion (11 papers), RNA Interference and Gene Delivery (9 papers) and Virus-based gene therapy research (7 papers). Julia Hegge is often cited by papers focused on Cardiac Ischemia and Reperfusion (11 papers), RNA Interference and Gene Delivery (9 papers) and Virus-based gene therapy research (7 papers). Julia Hegge collaborates with scholars based in United States, France and United Kingdom. Julia Hegge's co-authors include Jon A. Wolff, David L. Lewis, Mark Noble, Robert D. Lasley, Guofeng Zhang, Robert M. Mentzer, Hans Herweijer, Christine I. Wooddell, Holly Hamilton and Qili Chu and has published in prestigious journals such as Circulation, Nature Biotechnology and Circulation Research.

In The Last Decade

Julia Hegge

42 papers receiving 1.3k citations

Peers

Julia Hegge
Katie A. Sharff United States
Stacy Porvasnik United States
Yu‐Hua Chow United States
Sidney W. Fu United States
David H. Scoville United States
Yan Fan United States
Ming Du United States
Katie A. Sharff United States
Julia Hegge
Citations per year, relative to Julia Hegge Julia Hegge (= 1×) peers Katie A. Sharff

Countries citing papers authored by Julia Hegge

Since Specialization
Citations

This map shows the geographic impact of Julia Hegge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Hegge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Hegge more than expected).

Fields of papers citing papers by Julia Hegge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Hegge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Hegge. The network helps show where Julia Hegge may publish in the future.

Co-authorship network of co-authors of Julia Hegge

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Hegge. A scholar is included among the top collaborators of Julia Hegge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Hegge. Julia Hegge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wooddell, Christine I., Keith Blomenkamp, Ryan M. Peterson, et al.. (2020). Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease. JCI Insight. 5(12). 40 indexed citations
3.
Wong, So C., Weijun Cheng, Holly Hamilton, et al.. (2017). HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell Carcinoma. Molecular Cancer Therapeutics. 17(1). 140–149. 27 indexed citations
4.
Melquist, Stacey, Darren H. Wakefield, Holly Hamilton, et al.. (2016). Abstract 17167: Targeting Apolipoprotein(a) With a Novel RNAi Delivery Platform as a Prophylactic Treatment to Reduce Risk of Cardiovascular Events in Individuals With Elevated Lipoprotein (a). Circulation. 7 indexed citations
5.
Rozema, David B., Andrei V. Blokhin, Darren H. Wakefield, et al.. (2015). Protease-triggered siRNA delivery vehicles. Journal of Controlled Release. 209. 57–66. 31 indexed citations
6.
Wooddell, Christine I., David B. Rozema, Markus Hoßbach, et al.. (2013). Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection. Molecular Therapy. 21(5). 973–985. 241 indexed citations
7.
Wong, So C., Jason J. Klein, Holly Hamilton, et al.. (2012). Co-Injection of a Targeted, Reversibly Masked Endosomolytic Polymer Dramatically Improves the Efficacy of Cholesterol-Conjugated Small Interfering RNAs In Vivo. Nucleic Acid Therapeutics. 22(6). 380–390. 86 indexed citations
8.
Wooddell, Christine I., Julia Hegge, Guofeng Zhang, et al.. (2011). Dose Response in Rodents and Nonhuman Primates After Hydrodynamic Limb Vein Delivery of Naked Plasmid DNA. Human Gene Therapy. 22(7). 889–903. 25 indexed citations
9.
Zhang, Guofeng, Christine I. Wooddell, Julia Hegge, et al.. (2009). Functional Efficacy of Dystrophin Expression from Plasmids Delivered to mdx Mice by Hydrodynamic Limb Vein Injection. Human Gene Therapy. 21(2). 221–237. 32 indexed citations
10.
Asokan, Aravind, Jana L. Phillips, Chengwen Li, et al.. (2009). Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nature Biotechnology. 28(1). 79–82. 194 indexed citations
11.
Wooddell, Christine I., Guofeng Zhang, Jacob B. Griffin, et al.. (2009). Use of evans blue dye to compare limb muscles in exercised young and old mdx mice. Muscle & Nerve. 41(4). 487–499. 35 indexed citations
12.
Toumi, Hechmi, Julia Hegge, Владимир Субботин, et al.. (2005). Rapid Intravascular Injection into Limb Skeletal Muscle: A Damage Assessment Study. Molecular Therapy. 13(1). 229–236. 22 indexed citations
13.
Lasley, Robert D., Julia Hegge, Mark Noble, & Robert M. Mentzer. (1999). Evidence that cytosolic and ecto 5'-nucleotidases contribute equally to increased interstitial adenosine concentration during porcine myocardial ischemia. Basic Research in Cardiology. 94(3). 199–207. 10 indexed citations
14.
Lasley, Robert D., et al.. (1998). Adenosine attenuates in vivo myocardial stunning with minimal effects on cardiac energetics. Basic Research in Cardiology. 93(4). 303–312. 12 indexed citations
15.
Lasley, Robert D., Julia Hegge, Mark Noble, & Robert M. Mentzer. (1998). Comparison of Interstitial Fluid and Coronary Venous Adenosine Levels inIn VivoPorcine Myocardium. Journal of Molecular and Cellular Cardiology. 30(6). 1137–1147. 19 indexed citations
16.
Lasley, Robert D., et al.. (1995). Myocardial stunning: A therapeutic conundrum. Journal of Thoracic and Cardiovascular Surgery. 110(5). 1391–1401. 27 indexed citations
17.
Lasley, Robert D., et al.. (1995). Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. American Journal of Physiology-Heart and Circulatory Physiology. 269(4). H1460–H1466. 63 indexed citations
18.
Stringham, James C., et al.. (1992). LIMITATIONS OF HEART PRESERVATION BY COLD STORAGE. Transplantation. 53(2). 287–293. 69 indexed citations
19.
Swanson, David K., et al.. (1987). A comparison of blood and crystalloid cardioplegia during heart transplantation after 5 hours of cold storage. Journal of Thoracic and Cardiovascular Surgery. 93(5). 687–694. 10 indexed citations
20.
Haworth, Robert A., A B Goknur, Douglas R. Hunter, Julia Hegge, & Herbert A. Berkoff. (1987). Inhibition of calcium influx in isolated adult rat heart cells by ATP depletion.. Circulation Research. 60(4). 586–594. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026